Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of vascular disorders
3.2.1.2 Rising demand for minimally invasive therapeutic procedures
3.2.1.3 Regulatory approval of advanced sclerosants
3.2.1.4 Increasing adoption as a cost-effective alternative to surgery
3.2.2 Industry pitfalls and challenges
3.2.2.1 Rise related to adverse reactions and complications
3.2.2.2 Lack of reimbursement coverage
3.3 Growth potential analysis
3.4 Patent analysis
3.5 Gap analysis
3.6 Regulatory landscape
3.7 Technological landscape
3.8 Future market trends
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook
Chapter 5 Market Estimates and Forecast, By Agents, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Detergents
5.3 Chemical irritants
5.4 Osmotic agents
Chapter 6 Market Estimates and Forecast, By Therapy, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Liquid sclerotherapy
6.3 Ultrasound sclerotherapy
6.4 Foam sclerotherapy
6.5 Other therapies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Varicose veins
7.3 Hemorrhoids
7.4 Malformed lymph vessels
7.5 Hydroceles
7.6 Other applications
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 AngioDynamics
9.2 Bioniche Pharma Group
9.3 Boston Scientific Corporation
9.4 Changan Tianyu group
9.5 Chemische Fabrik Kreussler
9.6 Cook Medical
9.7 Endo-Flex (Meditek Systems)
9.8 Erbe Elektromedizin
9.9 LGM Pharma
9.10 Medtronic
9.11 MTW ENDOSKOPIE
9.12 Omega Labs
9.13 Perrigo Company
9.14 Samarth Life Sciences
9.15 Troikaa Pharmaceuticals
